Cargando…
Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study
BACKGROUND: Late-life depression is a common, chronic and recurring disorder for which guidelines recommend long-term therapy. The safety and efficacy of duloxetine for the treatment of major depressive disorder (MDD) were evaluated using data from elderly patients (age ≥ 65 years; n = 101) who part...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544561/ https://www.ncbi.nlm.nih.gov/pubmed/15585058 http://dx.doi.org/10.1186/1471-2318-4-11 |